Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tifcemalimab injection
DRUG
2 trials
Sponsors
Shanghai Junshi Bioscience Co., Ltd.
, Sichuan University
Conditions
Extensive-stage Small-cell Lung Cancer
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Phase 1
Low-dose Radiotherapy Combined with Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC
Not yet recruiting
NCT06732258
Sichuan University
Extensive-stage Small-cell Lung Cancer
Start: 2025-01-10
End: 2028-02-29
Target: 12
Updated: 2024-12-27
Phase 3
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
Recruiting
NCT06095583
Shanghai Junshi Bioscience Co., Ltd.
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Start: 2023-11-15
End: 2029-07-31
Target: 756
Updated: 2024-06-21